Royal Bank of Canada increased its position in Mineralys Therapeutics shares while an insider sold stock on June 30, 2026.
2 reports, 1 independent
Updated Aug 4
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada increased its position in Mineralys Therapeutics shares while an insider sold stock on June 30, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Royal Bank of Canada
financial institution in Canada
- Eric Warren
Related events
- A new entity bought shares of Royal Bank of Canada, and this purchase was disclosed to the Securities and Exchange Commission.
- Houlihan Lokey disclosed insider trading via SEC filing while Royal Bank of Canada increased its stake in the company's stock.
- Royal Bank of Canada increased its stock holdings in Option Care Health, Inc., which trades on the Nasdaq exchange, and the company filed disclosures with the SEC.
- Director Anthony Scott sold shares of Rackspace Technology following company disclosure to the SEC. Royal Bank of Canada also provided research reports on the stock.
- Royal Bank of Canada purchased shares of Capital Research Global Investors on August 27, 2026, amid increased institutional investor stakes.